# Renflexis

NDC: 78206-162
Generic name: infliximab
Labeler / Manufacturer: Organon LLC
Product type: HUMAN PRESCRIPTION DRUG
Marketing category: Biologic License Application
Dosage form: INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION
Routes: INTRAVENOUS
Marketing started: 20170421

FDA application: BLA761054

## Active ingredients

- INFLIXIMAB: 100 mg/1

## Pharmacological class

—

## External sources

- openFDA: https://api.fda.gov/drug/ndc.json?search=product_ndc:"78206-162"
- FDA NDC Directory: https://www.accessdata.fda.gov/scripts/cder/ndc/dsp_searchresult.cfm?p_ndc=78206-162
- DailyMed: https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=dbf738c4-3fac-4422-a9d8-51d9c83a8789